2012
DOI: 10.1007/s00259-012-2143-7
|View full text |Cite
|
Sign up to set email alerts
|

Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients

Abstract: This study supports the utility of FDG PET/CT scanning in severely neutropenic patients with five or more days of fever. Further evaluation of the contribution of FDG PET/CT in the management of FNP across a range of underlying malignancies is required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
37
0
3

Year Published

2013
2013
2018
2018

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(43 citation statements)
references
References 15 publications
2
37
0
3
Order By: Relevance
“…Guy et al [19] assessed the diagnostic performances of FDG PET/CT in 20 patients with febrile neutropenia, reporting a sensitivity of about 93 %. Dong et al [16] published a meta-analysis on the value of FDG PET/CT in the evaluation of FUO, reporting a pooled sensitivity of 83 %.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Guy et al [19] assessed the diagnostic performances of FDG PET/CT in 20 patients with febrile neutropenia, reporting a sensitivity of about 93 %. Dong et al [16] published a meta-analysis on the value of FDG PET/CT in the evaluation of FUO, reporting a pooled sensitivity of 83 %.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, the slight specificity of FDG PET/CT emerges as a potential advantage in the management of patients with inflammatory or infectious diseases [14]. Moreover, FDG PET/CT seems to be useful in the setting of unexplained inflammatory syndrome and fever of unknown origin (FUO) in both the overall population [15][16][17][18] and immunosuppressed patients [19,20]. Finally, FDG PET/CT plays a role in assessing treatment efficacy in neoplastic [21] and selected non-neoplastic conditions [22,23], leading to the detection of residual tumoral or inflammatory localizations.…”
Section: Introductionmentioning
confidence: 99%
“…La fiebre de origen desconocido es frecuente en pacientes con neutropenia inducida por quimioterapia 18 . Esto se explica no sólo por la neutropenia en sí, sino también por el daño de mucosas y endotelio secundarios a la quimioterapia y a la frecuente invasión con catéteres en estos pacientes 19,20 . Los principales factores de riesgo son el grado y la duración de la neutropenia 18 .…”
Section: Infeccionesunclassified
“…En un estudio de Koh et al en el que se incluyeron 107 pacientes con neutropenia febril y que se estudió a 37 con PET/CT y 76 por métodos convencionales, se detectó un foco en el 90% de los pacientes del primer grupo y en 70% del segundo 21 . En otro estudio que incluyó 20 pacientes neutropénicos con fiebre, en 8 se detectaron focos con PET/CT que no fueron detectados por métodos convencionales 20 . Teóricamente la disminución en el número de neutrófilos metabólicamente activados podría disminuir la sensibilidad del PET/CT, sin embargo la activación de macrófagos y también de las células del tejido conectivo adyacentes a un foco inflamatorio explicarían porque pueden encontrarse focos de aumento de metabolismo en este grupo 20 .…”
Section: Infeccionesunclassified
See 1 more Smart Citation